Emilia Romagna
Farmeconomia
View Archive InfoField | Value | |
Title |
Emilia Romagna
|
|
Creator |
Cavallo, Maria Caterina
Cipriani, Filippo Gerzeli, Simone Demarteau, Nadia Marocco, Alessia Bamfi, Francesco |
|
Subject |
Pharmacoeconomics; Health economics
Emilia Romagna; HPV vaccination; Economic & clinical impact |
|
Description |
In Emilia Romagna region 77,6% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering regional tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 51 cases of cervicocarcinoma and 22 related deaths and thus results to be cost-effective (29.903€/QALY). When the vaccination programme is extended to 16-year-old girls a further 47 cancer cases and 20 deaths could be prevented, with a very similar cost-effectiveness ratio. In Emilia Romagna region, the net cost for woman vaccinated is 177€ for the single cohort and 180€ for the multiple cohort.
|
|
Publisher |
SEEd Medical Publishers
|
|
Date |
2008-09-15
|
|
Type |
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion — |
|
Format |
application/pdf
|
|
Identifier |
https://journals.edizioniseed.it/index.php/FE/article/view/1007
10.7175/fe.v9i1S.1007 |
|
Source |
Farmeconomia. Health economics and therapeutic pathways; Vol 9, No 1S (2008); 43-45
2240-256X 1721-6915 |
|
Language |
eng
|
|
Relation |
https://journals.edizioniseed.it/index.php/FE/article/view/1007/1225
|
|
Rights |
Copyright (c) 2008 Farmeconomia. Health economics and therapeutic pathways
http://creativecommons.org/licenses/by-nc/4.0 |
|